Drug testing involves analyzing biological samples to identify drug presence in an individual's system. It is used in workplaces, sports, legal, and healthcare settings for safety, compliance, and diagnostic purposes. Methods include urine, blood, saliva, and hair tests, chosen based on detection requirements. Results can impact legal, occupational, or health situations and should be interpreted by professionals.
Sort by title | Sort by title | Sort by price | Sort by price
A 12 panel hair-based drug test screens for the presence of 12 different drugs of abuse, such as marijuana, cocaine, amphetamines, opiates, and others. This type of test is commonly used for various purposes, including pre-employment screenings, probation monitoring, and drug rehabilitation programs. Hair testing provides a longer detection window compared to urine tests, offering a more comprehensive assessment of drug use history. However, additional testing may be necessary to detect all drugs and substances for a thorough drug screening.
A 14-panel hair drug test is a comprehensive screening method that analyzes hair samples to detect 14 different drugs of abuse, including marijuana, cocaine, and others. Hair testing provides a longer detection window than urine or saliva tests and is commonly used in various settings like workplace testing and drug rehabilitation. External drug exposure can sometimes lead to false positives, so confirmation testing is often done. Additional testing may be needed to detect other substances for a thorough drug screening.
A 7 panel hair-based drug test screens for 7 drugs of abuse, including marijuana, cocaine, and others. This test is used in pre-employment screenings and drug rehab programs. Hair testing can detect drug use over a longer period than urine tests. Additional testing may be needed for a complete drug screening.
A 9 panel hair-based drug test screens for 9 drugs of abuse, including marijuana, cocaine, and others. It is used for pre-employment screenings, probation monitoring, and drug rehab programs. Hair testing offers a longer detection window than urine tests but may require additional testing for a complete drug screening.
The amphetamine screen and confirmation test is used to detect the presence of amphetamines in urine samples for drug testing programs. The initial screen is quick and inexpensive, with positive results followed by a more specific confirmation test to rule out false positives. This test is vital for ensuring accurate results and detecting amphetamine use in individuals.
The amphetamine screen, blood test can detect amphetamine and related substances in the bloodstream to confirm abuse, monitor treatment, or assess drug toxicity. The test involves a blood sample and may only show recent drug use. False positives can occur due to certain medications. For more information, consult a healthcare provider or drug testing professional.
A barbiturate screening and confirmation test detects barbiturates in urine samples. Barbiturates are central nervous system depressants with sedative effects. A qualitative method is used to analyse samples, with a confirmation test done if the screening is positive, using methods like gas chromatography-mass spectrometry to identify the specific type of barbiturate.
A barbiturates screen blood test detects the presence of barbiturates, which are CNS depressant drugs used for sedation and anaesthesia. The test can diagnose overdose, monitor therapy in patients, and detect drug abuse in forensic settings.
A benzodiazepine screen is a blood test used to detect benzodiazepines, medications commonly used for anxiety and insomnia which can also be abused. The test helps confirm medication use or abuse, monitor treatment compliance, and detect overdose risk. It identifies drugs like Xanax, Valium, and others to guide healthcare decisions.
Buprenorphine is used to treat opioid addiction, and urine tests can confirm proper medication use. The initial screening is done with an immunoassay test, followed by confirmation using GC-MS or LC-MS/MS if positive. Accurate results depend on proper sample collection and consideration of individual factors. These tests are helpful for monitoring treatment adherence and identifying misuse.
A cannabinoid (marijuana) screen is a test used to detect cannabinoids in a person's blood, showing recent marijuana use. It is commonly used in drug testing programs for various purposes. Results vary based on test sensitivity and marijuana usage frequency. Positive results don't always indicate recent use, as cannabinoids can linger in the body. Additional testing may be necessary for more precise timing. The screen serves as a helpful tool but should be analysed alongside other information for a complete assessment of drug use history.
A cocaine metabolite screen and confirmation test is used to detect cocaine metabolites in urine, which can indicate recent cocaine use. The test involves a screening test followed by a confirmation test for accuracy. While the screening test is quick and cost-effective, it may yield false positives. The confirmation test is more specific and accurate in distinguishing cocaine metabolites from other substances.
The cocaine screen and confirmation test uses a blood sample to detect cocaine in the system. The initial screen test provides quick results, while the confirmation test is more specific to confirm cocaine presence and avoid false positives. It is commonly used in forensic and legal settings to determine recent cocaine use.
A fentanyl screen and confirmation test is a lab test that detects fentanyl in urine. Fentanyl is a potent opioid used for pain relief but can be misused. Screening is quick and inexpensive, providing preliminary results. If positive, a confirmation test is done using specific techniques to confirm fentanyl presence and rule out false positives.
A blood test to monitor lithium levels is essential for patients taking lithium to treat bipolar disorder and other psychiatric conditions. The test involves drawing a blood sample, typically from a vein in the arm, and sending it to a laboratory for analysis. Following healthcare provider instructions, such as fasting before the test, is crucial. Symptoms of lithium toxicity should be reported immediately. Regular blood tests help ensure that patients are receiving the right dose of lithium for safe and effective treatment.
An LSD screen, urine test detects LSD in urine, a powerful hallucinogenic drug causing sensory distortions and altered reality perceptions. This test is useful for monitoring substance abuse and forensic purposes by analysing urine for LSD metabolites produced when the drug breaks down.
The MDMA (Ecstasy/Molly) urine test measures the presence of MDMA, a stimulant and hallucinogen commonly used recreationally. It uses immunoassay technology for screening and confirmatory GC/MS testing if needed. Detection window is usually 1-3 days post-use, influenced by various factors. This test is important for detecting recent MDMA use and monitoring substance abuse.
An MDMA and metabolite screen urine test is used to detect MDMA (Molly/Ecstasy) and its breakdown products in urine samples. This test is often used to confirm MDMA use, monitor substance abuse treatment, and for drug screening purposes. The test can identify MDMA and its metabolites, such as MDA, in urine samples for several days after ingestion. It's important to note that MDMA use is illegal and can have harmful effects on the body.
Methadone, a synthetic opioid used in opioid addiction treatment, is detected in urine samples through a screening and confirmation test. The initial screening is done with immunoassay techniques, and if positive, a more specific test like GC/MS or LC-MS/MS is used. This test is used to monitor methadone levels in addiction treatment, ensure compliance, and detect unauthorized use.
A methaqualone screen is a urine test that detects the presence of the sedative-hypnotic drug in the urine. It is used to monitor drug use or detect overdose. The initial screening test involves collecting a urine sample and using immunoassay techniques. A positive result is confirmed with a more specific test like GC-MS.
A nicotine metabolite screen is a test that measures nicotine and its byproducts in urine. It is used to assess nicotine exposure in smokers, individuals using tobacco products, or those exposed to secondhand smoke. The test is also useful for monitoring tobacco cessation programs and evaluating interventions to reduce tobacco use. It provides valuable information on nicotine exposure levels and aids in developing personalized treatment plans for individuals trying to quit smoking or cut down on tobacco use.
A nicotine metabolite screen measures levels of nicotine-derived metabolites in the blood to assess nicotine exposure and monitor tobacco or nicotine product use. These metabolites are products of nicotine breakdown and can be detected in the blood for days after nicotine exposure.
An opiate screen and confirmation test in urine is used to detect the presence of opiates, a class of drugs derived from the opium poppy plant or synthetic versions that act on opioid receptors in the body. The initial screening test detects opiate metabolites, and if positive, a confirmation test with methods like GC/MS is done. Results can help healthcare or law enforcement determine recent opiate use, but prescription medications containing opiates can also trigger a positive result.
The opioid screen in blood is a test that identifies opioid drugs in the bloodstream, including prescription painkillers and illegal substances like heroin. It is utilized to monitor opioid use, screen for drug abuse, and identify opioid overdose.
The Oxycodone screen and confirmation test is used to detect the presence of oxycodone in urine. This opioid medication is commonly used for treating moderate to severe pain. The screening test uses an immunoassay method to quickly detect oxycodone, with confirmation tests like GC/MS or LC/MS providing more accurate results. Interpretation of test results should be done by a healthcare provider considering the individual's medical history and other medications taken. A positive result may indicate recent use or misuse of oxycodone, while a negative result does not rule out its use.
The Oxycodone/Oxymorphone and Metabolite Screen, Urine test is used to detect oxycodone, oxymorphone, and their metabolites in urine samples. These substances are used for pain relief, and the test helps to monitor drug compliance, identify drug abuse, confirm drug toxicity, and can be used in workplace drug testing or forensic investigations.
Phencyclidine, or PCP, is a hallucinogenic drug that can cause paranoia. Tests for PCP in urine samples are common to detect recent use. The Phencyclidine screen and confirmation test uses immunoassay techniques for initial screening, followed by gas chromatography/mass spectrometry for confirmation. False positives can occur, so confirmatory testing is crucial. PCP can typically be detected in urine for 1-3 days after use.
Phencyclidine (PCP) is a potent hallucinogenic drug with harmful effects on the body and mind. A PCP screen and confirmation test in blood can detect its presence. The screening test analyzes a blood sample with a test kit, and if positive, a confirmation test using advanced techniques like gas chromatography-mass spectrometry is performed. PCP is a controlled substance with legal consequences, and these tests are crucial for medical and legal purposes in cases of suspected PCP use.
Propoxyphene is an opioid analgesic used to treat mild to moderate pain. Screening and confirmation tests in urine monitor drug levels to ensure proper medication use. The screening test employs an immunoassay to detect the drug, with a positive result leading to a confirmation test using GC/MS. It is crucial to follow instructions, including abstaining from interfering substances. These tests aid in monitoring medication adherence and detecting potential drug misuse or abuse.
A urine drug test for psilocybin mushrooms can typically detect the substance for 1-3 days after use. Different factors like metabolism, frequency of use, and dosage can impact detection times. Tests such as immunoassay screening and GC-MS confirmation can identify psilocybin specifically.
A urine test for tramadol is conducted to identify the presence of the medication in a person's body. Tramadol is a prescription drug used for pain relief. The test involves screening for tramadol metabolites in the urine and confirming the presence of tramadol and its metabolites using specific methods like GC-MS or LC-MS/MS. The results aid in monitoring patients' medication adherence and identifying any misuse of tramadol. Adherence to instructions for urine sample collection is crucial for accurate test results.
USLABTESTING